JPS59137417A - 人尿由来コロニ−形成刺激因子及びカリクレインの製造法 - Google Patents

人尿由来コロニ−形成刺激因子及びカリクレインの製造法

Info

Publication number
JPS59137417A
JPS59137417A JP58011317A JP1131783A JPS59137417A JP S59137417 A JPS59137417 A JP S59137417A JP 58011317 A JP58011317 A JP 58011317A JP 1131783 A JP1131783 A JP 1131783A JP S59137417 A JPS59137417 A JP S59137417A
Authority
JP
Japan
Prior art keywords
kallikrein
human urine
buffer
stimulating factor
colony formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58011317A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6160049B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Satoru Funakoshi
船越　哲
Kazuo Morimoto
森本　和郎
Morio Kuboyama
久保山　盛雄
Nobuya Yanagiuchi
延也 柳内
Muneo Yamada
宗夫 山田
Hajime Yokota
横田　肇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Morinaga Milk Industry Co Ltd
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Morinaga Milk Industry Co Ltd, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Priority to JP58011317A priority Critical patent/JPS59137417A/ja
Priority to CA000444114A priority patent/CA1200489A/en
Priority to GB08334220A priority patent/GB2134528B/en
Priority to AU22806/83A priority patent/AU545411B2/en
Priority to US06/568,259 priority patent/US4482485A/en
Priority to DE3402647A priority patent/DE3402647C2/de
Priority to FR8401202A priority patent/FR2540121B1/fr
Publication of JPS59137417A publication Critical patent/JPS59137417A/ja
Publication of JPS6160049B2 publication Critical patent/JPS6160049B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
JP58011317A 1983-01-28 1983-01-28 人尿由来コロニ−形成刺激因子及びカリクレインの製造法 Granted JPS59137417A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP58011317A JPS59137417A (ja) 1983-01-28 1983-01-28 人尿由来コロニ−形成刺激因子及びカリクレインの製造法
CA000444114A CA1200489A (en) 1983-01-28 1983-12-22 Method of preparation of human urine origin colony- stimulating factor and kallikrein
GB08334220A GB2134528B (en) 1983-01-28 1983-12-22 Method of isolation of colony-stimulating factor and kallikrein originating from human urine
AU22806/83A AU545411B2 (en) 1983-01-28 1983-12-22 Method of isolating human urine origin colony-stimulating factor and kallikrein from urine
US06/568,259 US4482485A (en) 1983-01-28 1984-01-04 Method of preparation of human urine origin colony-stimulating factor and kallikrein
DE3402647A DE3402647C2 (de) 1983-01-28 1984-01-26 Verfahren zur Gewinnung von koloniestimulierendem Faktor und Kallikrein aus menschlichem Urin
FR8401202A FR2540121B1 (fr) 1983-01-28 1984-01-26 Procede de preparation d'un facteur stimulant des colonies et de kallikreine provenant de l'urine humaine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58011317A JPS59137417A (ja) 1983-01-28 1983-01-28 人尿由来コロニ−形成刺激因子及びカリクレインの製造法

Publications (2)

Publication Number Publication Date
JPS59137417A true JPS59137417A (ja) 1984-08-07
JPS6160049B2 JPS6160049B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-12-19

Family

ID=11774637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58011317A Granted JPS59137417A (ja) 1983-01-28 1983-01-28 人尿由来コロニ−形成刺激因子及びカリクレインの製造法

Country Status (7)

Country Link
US (1) US4482485A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS59137417A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU545411B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1200489A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3402647C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2540121B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2134528B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62252729A (ja) * 1986-01-22 1987-11-04 Chugai Pharmaceut Co Ltd 造血機能回復促進剤
JPH05163158A (ja) * 1991-12-13 1993-06-29 Sanwa Kagaku Kenkyusho Co Ltd 人尿性キニノゲナーゼを有効成分とする皮膚潰瘍の予防及び治療剤
WO1995016205A1 (en) * 1993-12-10 1995-06-15 Ciba-Geigy Ag Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
EP1413784A2 (en) 2002-10-22 2004-04-28 Takeuchi Precision Works Co., Ltd. Linear motion guide ball bearing device and manufacturing method

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
US5792450A (en) * 1985-02-05 1998-08-11 Chiron Corporation Purified human CSF-1
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
US5573930A (en) * 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US6146851A (en) * 1985-02-05 2000-11-14 Chiron Corporation DNA encoding NV2 (long form) and carboxy truncated fragments thereof
DE3689391T2 (de) * 1985-02-05 1994-06-30 Cetus Oncology Corp., Emeryville, Calif. Rekombinanter koloniestimulierender faktor-1.
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
ATE80894T1 (de) * 1985-02-05 1992-10-15 Cetus Oncology Corp Reinigung des natuerlichen kolonie-stimulierenden faktors-1.
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
AU605901B2 (en) * 1987-09-11 1991-01-24 Ares Trading S.A. Purification process
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5492834A (en) * 1993-07-09 1996-02-20 Beckman Instruments, Inc. Method of sample preparation for urine protein analysis with capillary electrophoresis
US20030212021A1 (en) * 2001-01-25 2003-11-13 Frost Gregory I. Myeloid colony stimulating factor and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2874088A (en) * 1952-08-25 1959-02-17 Bayer Ag Recovery of kallikrein
DE1102973B (de) * 1960-03-25 1961-03-23 Bayer Ag Verfahren zur Herstellung von hoch gereinigten Kallikrein-Praeparaten
BE790794A (fr) * 1971-11-03 1973-04-30 Bayer Ag Procede de purification et de cristallisation de kallicreine
US3905870A (en) * 1972-11-03 1975-09-16 Bayer Ag Purification of kallikrein
JPS5544726B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-05-17 1980-11-13
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
JPS5517364A (en) * 1978-07-25 1980-02-06 Toho Yakuhin Kogyo Kk Purification of pancreatic kallikrein
IN150740B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4178285A (en) * 1978-12-20 1979-12-11 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
US4342828A (en) * 1979-07-20 1982-08-03 Morinaga Milk Industry Co., Ltd. Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
JPS5758629A (en) * 1980-09-25 1982-04-08 Morinaga Milk Ind Co Ltd Separating and purifying method of colonization stimulating factor and callicrein in human urine
DE3103257A1 (de) * 1981-01-31 1982-08-26 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung des hochreinen enzyms kallikrein aus schweinepankreas-extrakten
US4359415A (en) * 1981-06-03 1982-11-16 University Of Tennessee Research Corporation Isolation of an antineoplastic protein fraction and an antineoplastic peptide fraction from human urine

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62252729A (ja) * 1986-01-22 1987-11-04 Chugai Pharmaceut Co Ltd 造血機能回復促進剤
JPH05163158A (ja) * 1991-12-13 1993-06-29 Sanwa Kagaku Kenkyusho Co Ltd 人尿性キニノゲナーゼを有効成分とする皮膚潰瘍の予防及び治療剤
WO1995016205A1 (en) * 1993-12-10 1995-06-15 Ciba-Geigy Ag Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
EP1413784A2 (en) 2002-10-22 2004-04-28 Takeuchi Precision Works Co., Ltd. Linear motion guide ball bearing device and manufacturing method

Also Published As

Publication number Publication date
GB2134528B (en) 1986-08-20
GB8334220D0 (en) 1984-02-01
AU2280683A (en) 1984-08-02
CA1200489A (en) 1986-02-11
DE3402647C2 (de) 1986-11-27
FR2540121B1 (fr) 1987-09-04
AU545411B2 (en) 1985-07-11
JPS6160049B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-12-19
DE3402647A1 (de) 1984-08-02
FR2540121A1 (fr) 1984-08-03
GB2134528A (en) 1984-08-15
US4482485A (en) 1984-11-13

Similar Documents

Publication Publication Date Title
JPS59137417A (ja) 人尿由来コロニ−形成刺激因子及びカリクレインの製造法
AT407115B (de) Verfahren zur herstellung eines konzentrates von standardisiertem, menschlichem von willebrand-faktor
CA1128881A (en) Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
US4341764A (en) Method of preparing fibronectin and antihemophilic factor
DE69002427T2 (de) Verfahren zur Herstellung eines Konzentrats des Faktor VIII-von Willebrand-Faktor-Komplexes der Blutgerinnung aus Vollplasma.
US4022758A (en) Isolation of coagulation factors I and VIII from biological material
JPS6030291B2 (ja) 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
US4314994A (en) Process for obtaining a plasminogen activator
EP0271885B1 (de) Arzneimittel enthaltend das Gewebeprotein PP4, Verfahren zur Herstellung von PP4 und zu seiner Pasteurisierung sowie die Verwendung von PP4
DE3019847C2 (de) Verfahren zur Herstellung von Humaninterferon
JPS58201794A (ja) ヒトインターフェロンβの濃縮精製法
US4455300A (en) Fibronectin compositions
JPH07116235B2 (ja) 抗トロンビンｉｉｉ濃縮物の製造法
DE69433875T2 (de) Verfahren zur präparation von humanem aktiviertem protein c
DE4435520A1 (de) Verfahren zur Trennung von rekombinantem pro-Faktor IX von rekombinantem Faktor IX
Bruning et al. Prothrombal: a new concentrate of human prothrombin complex for clinical use
DE1442134B2 (de) In vivo antikoagulierend wirkendes und defibrinierendes Enzym
DE69719382T2 (de) VERFAHREN ZUR HERSTELLUNG VON rDSPA Alpha1
JPS6159610B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US5470965A (en) Complexable heterogenous oligosaccharides and alpha-hydosanes having therapeutical activity, process for their preparation and related pharmaceutical compositions
JPS6041615A (ja) コロニ−形成刺激因子の製造方法
CZ289560B6 (cs) Způsob výroby přípravku obsahujícího hyaluronidázu
RU2799637C1 (ru) Способ получения биологически активного пептидно-аминокислотного препарата на основе плазмы крови человека
EP1002803A1 (en) Method for the isolation of legume lectins and their use as a medicament